Pfizer bought G...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Global Blood Therapeutics
Pfizer bought Global Blood Therapeutics
10/5/22 at 16:56
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.
Global Blood Therapeutics
Review
Source:
investors.pfizer.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Seligdar received a license for geological exploration at the Fedorovskaya area
2/3/25
SELG
Russneft replenished production by 171%
2/3/25
RNFT
Aeroflot reported for 2024 by RAS
2/3/25
AFLT
Cherkizovo reports for 2024 by RAS
2/3/25
GCHE
Severstal will not pay dividends for Q4 2024
2/3/25
CHMF
Severstal reports for 2024 by IFRS
2/3/25
CHMF
Severstal's capex in 2025 will be β½169 billion
2/3/25
CHMF
Severstal sales to grow by 1% in 2024
2/3/25
CHMF
Rosseti proposed to change the procedure for calculating payment for its services
2/3/25
FEES
MGKL revenue in January increased 4.7 times
2/3/25
MGKL
«
Previous
1
2
3
4
5
6
7
8
9
10
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
investors.pfizer.com investors.pfizer.com investors.pfizer.com
English (US) 